Heloisa P. Soares, Samuel Crawford, Anteneh A. Tesfaye, Antonio Nakasato, Jasjit Multani, Elizabeth J. Wang, Jeetvan Patel, Aman Chauhan. "Clinical outcomes of [
                    <sup>177</sup>
                    Lu]Lu-DOTA-TATE (
                    <sup>177</sup>
                    Lu-DOTATATE) vs everolimus (EVE) in managing patients (pts) with gastroenteropancreatic-neuroendocrine tumors (GEP-NETs): Real-world analysis of the PRIME initiative.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e16316